Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial

BACKGROUND: The Melody valve was developed to extend the useful life of previously implanted right ventricular outflow tract (RVOT) conduits or bioprosthetic pulmonary valves, while preserving RV function and reducing the lifetime burden of surgery for patients with complex congenital heart disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Thomas K., McElhinney, Doff B., Vincent, Julie A., Hellenbrand, William E., Cheatham, John P., Berman, Darren P., Zahn, Evan M., Khan, Danyal M., Rhodes, John F., Weng, Shicheng, Bergersen, Lisa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765216/
https://www.ncbi.nlm.nih.gov/pubmed/34930015
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.121.010852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765216/
https://www.ncbi.nlm.nih.gov/pubmed/34930015
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.121.010852

Ejemplares similares